clinical trial · NCT07541261
A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
Janssen Research & Development, LLC·—·recruiting·n = 100
ColitisUlcerativeCrohn Disease
brief summary
The main purpose of this study is to evaluate treatment persistence of guselkumab (that is how long a person keeps taking their prescribed medicine or continues with their treatment plan without stopping) in participants with moderate to severe crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are Inflammatory bowel disease, a group of inflammatory conditions of the colon and small intestine.
started
May 12, 2026
primary completion
Jan 2, 2029
completion
Jan 29, 2029
last updated
Jul 2, 2026
official title
A Multi-Center, Non-Interventional Study on Effectiveness and Treatment Persistence of Guselkumab in Patients With ULcerative Colitis and Crohn's DiseasE in Real-World Practice in Saudi Arabia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol